← back to search

Brenda E. Porter

Palo Alto University · US
Area of research
Psychiatry and Mental health · Cellular and Molecular Neuroscience
Research interest
Research interests include Epilepsy, Medicine, Pediatrics, Cortical dysplasia, Biology, and Randomized controlled trial.
h-index
citations
625
works
11
NIH funding
primary concept
email

Recent publications

Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial
Pediatric Neurology 2024cited by 10position: middledoi
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The <scp>PREVeNT</scp> Trial
Annals of Neurology 2023cited by 58position: middledoi
Efficacy and safety of perampanel in a randomized, placebo-controlled trial with an open-label extension in patients with seizures associated with Lennox-Gastaut syndrome (LGS)
Journal of the Neurological Sciences 2023cited by 1position: firstdoi
Missense variants in the voltage sensing and pore domain of <i>KCNH5</i> cause neurodevelopmental phenotypes including epilepsy
medRxiv 2022cited by 0position: middledoi
Real-World Preliminary Experience With Responsive Neurostimulation in Pediatric Epilepsy: A Multicenter Retrospective Observational Study
Neurosurgery 2021cited by 55position: middledoi
Pilot Study of Neurodevelopmental Impact of Early Epilepsy Surgery in Tuberous Sclerosis Complex
Pediatric Neurology 2020cited by 44position: middledoi
Somatic <i>SLC35A2</i> variants in the brain are associated with intractable neocortical epilepsy
Annals of Neurology 2018cited by 134position: middledoi
Mutations in the Na+/Citrate Cotransporter NaCT (SLC13A5) in Pediatric Patients with Epilepsy and Developmental Delay
Molecular Medicine 2016cited by 78position: middledoi
Human genome meeting 2016
Human Genomics 2016cited by 41position: middledoi
Perineuronal net degradation in epilepsy
Epilepsia 2015cited by 95position: lastdoi
MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways
Neurogenetics 2013cited by 109position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mustafa Şahin · Ankara Bilkent City Hospital2 papers (2023–2024)Rajsekar R. Rajaraman · Neurobehavioral Systems2 papers (2023–2024)Stephanie C. Randle · Seattle Children's Hospital2 papers (2023–2024) · 2 papers (2023–2024)Darcy A. Krueger · Tufts University2 papers (2023–2024)Sarah O’Kelley · University of Alabama at Birmingham2 papers (2023–2024)Mary Kay Koenig · The University of Texas at Austin2 papers (2023–2024)Tarrant McPherson · Emory University2 papers (2023–2024)Gary Cutter · Epilepsy Foundation2 papers (2023–2024)Danielle Nolan · University of Michigan–Ann Arbor2 papers (2023–2024) · 2 papers (2023–2024) · 2 papers (2023–2024)Hope Northrup · Memorial Hermann2 papers (2023–2024)Jurriaan M. Peters · Boston Children's Hospital2 papers (2023–2024)Melissa A. Richard · National Human Genome Research Institute1 papers (2024–2024) · 1 papers (2021–2021)Stephanie Rogers · University of Nevada, Reno1 papers (2015–2015)Ana M. Pajor · University of California San Diego1 papers (2016–2016)Jenna Klotz · Palo Alto University1 papers (2016–2016)E. Martina Bebin · University of Alabama at Birmingham1 papers (2023–2023)